User cases on hazard and potency assessment Join us for this free webinar to get the latest news about the in vitro GARD™ assays and how they are used across various industries to fill data gaps in sensitizing hazard and potency assessment of chemicals and medical devices. Key topics We will provide several user cases […]
Webinaire en français (in French) Participez à ce webinaire sur les nouvelles technologies in vitro utilisées pour l’évaluation des produits cosmétiques organisé par PKDerm, GenEvolutioN et SenzaGen avec la participation de CEHTRA – experts en toxicologie. Suite au grand intérêt porté à la précédente édition de notre webinaire Cosmetic 3.0, nous sommes ravis de vous convier à […]
In this webinar you will learn how combining genomics and machine learning provides a highly accurate in vitro method for qualitative and quantitative skin sensitizing potency assessment, filling in data gaps in safety testing projects. The webinar will last around 30 minutes, followed by a live Q&A. Even If you cannot attend the live event, […]
This presentation will introduce GARDskin Dose-Response assay, a novel approach for the assessment of relative skin sensitizing potency on a continuous scale. Results demonstrate that induction of toxicity pathways in GARDskin Dose-Response appears to be highly dose-dependent, and the lowest concentration required to induce a positive classification in the assay correlates strongly and significantly with […]
Join our upcoming webinar to explore the recent advancement in GARD® for Skin Sensitization assessment, with a specific focus on substances that fall outside the applicability domains of the conventional in vitro assays in the OECD Test Guidelines. Our skin sensitization experts will address challenges posed by various Difficult-to-Test substances, discussing the applicability domain of […]
Spotlight on in vitro quantitative assessment of skin sensitizing potency. Join our upcoming webinar to explore the recent advancement in GARD® for quantitative assessment of skin sensitizing potency. This session will present a meta-analysis of GARD® data covering over 200 chemicals, including three blinded datasets generated in collaboration with industry partners. These data will demonstrate […]
Join us for a special re-run of our popular GARD® webinar to explore the recent advancement in Skin Sensitization testing, focusing on substances that fall outside the applicability domains of the conventional in vitro assays in the OECD Test Guidelines. Our skin sensitization experts will address challenges posed by various "Difficult-to-Test" substances, discussing the applicability […]
Join SenzaGen and industry leaders from Clarins and Bic Skin Creative for an in-depth webinar on using GARD® assays for skin sensitization testing. Learn how this innovative technology overcomes the unique challenges of testing complex Natural Extracts, which often fall outside the scope of traditional methods in OECD 442E Test Guidelines. Through case studies, we will showcase […]
Join us for an insightful webinar on the evolving role of New Approach Methodologies (NAMs) in regulatory biological safety assessments and how they can be used to help develop safe materials in the pre-regulatory space. With shifting standards and increasing adoption of NAMs, understanding their impact is more critical than ever. In this webinar, Dr […]
Bringing high performance and extended applicability to Defined Approaches for Skin Sensitization (DASS) Join our webcast to learn more about the inclusion of GARD®skin in OECD TG 497— what it means and how it can support your regulatory testing strategy. Defined Approaches for Skin Sensitization (DASS) is a key regulatory guideline for combining validated in […]
